Chinese F&B Firm Wahaha Invests Billions of Yuan in New Healthcare Business May 16, 2020 Life Science
Healthcare Roundup – Small vaccine developers up in wake of Sorrento rally, Head of White House COVID-19 vaccine drive bullish on timeline May 15, 2020 Life Science
SciMount announces FDA approval of SMP-100’s IND application for the treatment of Irritable Bowel Syndrome May 14, 2020 Life Science
Healthcare Roundup – Co-Diagnostics reverses rally after Hindenburg short call, Aurora Cannabis up 13% after revenue beat, improving cash flow May 14, 2020 Life Science
Healthcare Roundup – U.S. first up to receive Sanofi COVID-19 vaccine, Abbott’s COVID-19 test pain is Co-Diagnostics’ gain May 13, 2020 Life Science
Healthcare Roundup – House Democrats release $3T coronavirus relief bill, Gilead inks deals to sell remdesivir in 127 countries May 12, 2020 Life Science
Healthcare Roundup – New York City likely to stay in lockdown into June, Novavax up 26% on COVID-19 vaccine funding May 11, 2020 Life Science
Healthcare Roundup – AbbVie finalizes Allergan takeover, FDA OKs emergency use of COVID-19 test with saliva specimens May 8, 2020 Life Science
Healthcare Roundup – White House not on board with CDC reopening guidelines, Gilead confirms remdesivir approval in Japan for severe COVID-19 May 7, 2020 Life Science
Healthcare Roundup – White House coronavirus task force to ‘continue indefinitely’, Sinovac COVID-19 vaccine shows positive effect May 6, 2020 Life Science
Healthcare Roundup – FDA OKs emergency use of PerkinElmer COVID-19 blood test, Athersys up 3% premarket May 5, 2020 Life Science
Healthcare Roundup – Vir and Alnylam identify inhalable drug candidate for COVID-19, AmerisourceBergen eyes Walgreens’ drug distribution operation May 5, 2020 Life Science
Utrecht University, Erasmus Medical Center and Harbour BioMed Researchers Report Discovery of Antibody that Blocks Novel Coronavirus SARS-CoV-2 Infection in Cells May 4, 2020 Life Science
Ascentage Pharma’s Core Drug Candidate HQP1351 Granted Orphan Drug Designation by the US FDA for the Treatment of Patients with Chronic Myeloid Leukemia May 4, 2020 Life Science